The U.S. Food and Drug Administration (FDA) last month approved a new indication for somapacitan-beco injection 5 mg, 10 mg, or 15 mg for the treatment of children aged 2.5 years and older who have growth failure due to inadequate secretion of endogenous growth hormone. Novo Nordisk is marketing the treatment as Sogroya® The FDA approval...
Honored by both the Endocrine Society and the European Society of Endocrinology with the 2023 Transatlantic Alliance Award, George Chrousos, MD, ScD, has made significant contributions to endocrine research on both sides of the Atlantic! Endocrine News speaks with Chrousos about what this award means to him, conducting pioneering research on two different continents, the...Rebound Weight Gain in Children with Obesity Linked to Disconnect between Brain and Gut
Children with obesity who have recently lost weight are more likely to show hunger-related activity in their brains after a meal, according to research presented at the 60th Annual European Society for Paediatric Endocrinology Meeting. This brain activity, reflecting that they were unsatisfied by their meal, happens even though their gut hormone levels have changed, as...
Excessive Smartphone Screen Time Linked to Earlier Puberty Onset
Exposure to blue light through regular use of tablets and smartphones may alter hormone levels and increase the risk of earlier puberty, according to data from a rat study presented last month at the 60th Annual European Society for Paediatric Endocrinology Meeting in Rome. Longer duration of blue light exposure was associated with earlier puberty...
Babies Exposed to Cannabis in the Womb May Be at Risk for Obesity, High Blood sugar
Both CBD and THC put children at risk despite CBD being marketed as having health benefits. Cannabis use among pregnant women is on the rise and may be associated with negative health outcomes in children, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. A 2016 study in...
Shock to the System: Pediatric Type 1 Diabetes Patients and Trauma
A new study seems to suggest that while trauma and post-traumatic stress syndrome are common in kids with type 1 diabetes, they have little to no impact on their diabetes self-management. However surprising this finding may be to researchers, it further stresses the need for multidisciplinary teams to care for these patients. Children suffering traumatic...
In November, the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the granting of a marketing authorization for Ascendis Pharma’s lonapegsomatropin (TransCon hGH), a long-acting once-weekly, transiently pegylated somatropin that in the body releases somatropin, indicated for growth failure in children and adolescents aged from 3 years...
Rapid uptake of long-acting growth hormones (GH) is set to shake up the growth hormone deficiency (GHD) space in the three major markets (3MM): the US, Germany, and Japan. These therapies are projected to capture more than 90% of market share in this region by 2030 due to their potential to improve patient convenience and...
